Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02728804 · ClinicalTrials.gov registry record
S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
A clinical trial, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- 380
- Enrollment target
NCT02728804: Completed study, sponsored by SWOG Cancer Research Network.
NCT02728804 is a clinical trial that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 380 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02728804 has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- 380 participants
- Enrollment target
Study Summary
This clinical trial studies the use of the financial impact assessment tool in patients with colorectal cancer that has spread from the primary site to other places in the body. Gathering information about patients with colorectal cancer over time may help doctors better understand the financial impact of cancer and help patients avoid financial problems during treatment.
Primary Outcome
The cumulative incidence estimates of participants experiencing both major financial hardship (MFH) and multiple financial hardships will be reported. This estimate is calculated over a 12 month period; due to participant drop out throughout this period, the calculated cumulative incidence for the participants analyzed at the 12 month mark does not equate to a whole number. A major financial hardship is defined as one or more of the following: debt accumulation of any amount, selling or refinanc
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2016-06-22 |
| Est. Completion | 2020-11-13 |
What the finished NCT02728804 record still lists
NCT02728804 is an observational study that tracks outcomes without assigning an intervention. The registered 380 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT02728804 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02728804 about?
NCT02728804 is a clinical study titled "S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer". This clinical trial studies the use of the financial impact assessment tool in patients with colorectal cancer that has spread from the primary site to other places in the body. Gathering information about patients with colorectal cancer over time may help doctors better understand the financial imp...
What is the current status of trial NCT02728804?
This trial is currently completed. The enrollment target is 380 participants. The study started on 2016-06-22. Estimated completion is 2020-11-13.
What interventions are being tested in trial NCT02728804?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT02728804?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI